Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Other Accumulated Expenses (2023 - 2025)

Profound Medical has reported Other Accumulated Expenses over the past 3 years, most recently at $944000.0 for Q4 2025.

  • Quarterly results put Other Accumulated Expenses at $944000.0 for Q4 2025, down 47.67% from a year ago — trailing twelve months through Dec 2025 was $944000.0 (down 47.67% YoY), and the annual figure for FY2025 was $944000.0, down 47.67%.
  • Other Accumulated Expenses for Q4 2025 was $944000.0 at Profound Medical, up from $630000.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for PROF hit a ceiling of $1.8 million in Q4 2024 and a floor of $509000.0 in Q2 2025.
  • Median Other Accumulated Expenses over the past 3 years was $949500.0 (2025), compared with a mean of $974333.3.
  • Biggest five-year swings in Other Accumulated Expenses: skyrocketed 79.68% in 2024 and later tumbled 47.67% in 2025.
  • Profound Medical's Other Accumulated Expenses stood at $1.0 million in 2023, then skyrocketed by 79.68% to $1.8 million in 2024, then tumbled by 47.67% to $944000.0 in 2025.
  • The last three reported values for Other Accumulated Expenses were $944000.0 (Q4 2025), $630000.0 (Q3 2025), and $509000.0 (Q2 2025) per Business Quant data.